Navigation Links
Exonhit and BGI announce successful completion of a promising next-generation sequencing project
Date:7/21/2011

July 21, 2011 Exonhit (Alternext: ALEHT), a biotech company focused on personalized medicine, and BGI, the world's largest genome organization, are pleased to announce the successful completion of a project dedicated to expanding Exonhit's Genome Wide SpliceArray to an additional strategic preclinical animal model species.

To answer the need for a comprehensive understanding of gene deregulation and the expanding interest in developing biomarkers and molecular diagnostic tests for complex diseases, Exonhit and BGI decided to leverage their technology and know-how by combining the complementary features of massive parallel sequencing and Exonhit's proprietary SpliceArray platform.

"Combining BGI's next-generation sequencing's ability with the profiling efficiency of Exonhit unique SpliceArray platform to discover new transcript content will enable a better understanding of the biology contributing to the onset and progression of disease. This new powerful combination will facilitate the rapid discovery, development and commercialization of the most relevant therapeutics, biomarkers and molecular diagnostics. We look forward to working with BGI as a preferred partner on future discovery projects," commented Matthew Pando, Ph.D., Executive Vice President, Therapeutics at Exonhit.

"There is a high need for biomarker discovery as Pharma and Biotech players search for prognostic and predictive biomarkers in animal models, for designing clinical trials and developing companion diagnostics," said Zifei Yang, Director of Pharma Business Development at BGI. "BGI Europe is pleased to partner with Exonhit to leverage BGI next-generation sequencing technology with Exonhit's SpliceArray platform."


'/>"/>

Contact: Lei Su
BGI-Marketing@genomics.cn
86-075-525-283-805
Beijing Genomics Institute
Source:Eurekalert

Page: 1

Related biology news :

1. A major prize in the chemical sciences announced by the Camille and Henry Dreyfus Foundation
2. 2008 SNM Wagner-Torizuka Fellowships announced
3. NIAID announces 25 new awards to develop radiation countermeasures
4. Aware Announces Q3 2008 Earnings Conference Call
5. Governor Doyle announces historic genomic research collaboration
6. BIO-key(R) Announces Additional $245,000 in Third Quarter Public Safety Orders
7. San Diego Supercomputer Center and UCSD announce Triton Resource
8. NARSAD announces 2008 Prizes for Outstanding Achievement in Research on Mental Health Disorders
9. GUMC and Oak Ridge National Labs announce unique research partnership
10. Parkinsons Disease Foundation announces award of $150,000
11. Jefferson Department of Surgery announces new pancreas tumor registry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
(Date:4/13/2017)... , April 13, 2017 According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... Tbilisi, Georgia (PRWEB) , ... October 11, 2017 , ... ... disaster, taking the lives of over 5.5 million people each year. Especially those living ... the greenovative startup Treepex - based in one of the most pollution-affected countries globally ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder ... local San Diego Rotary Club. The event entitled “Stem Cells and ... had 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: ...
Breaking Biology Technology: